期刊文献+

蚁附蠲痹超细微粉对佐剂性关节炎大鼠TLR/TRAF/Fas信号转导的影响

Effect of Yifu-Juanbi micropowder on the TLR/TRAF/Fas signal transduction of adjuvant arthritis rats
下载PDF
导出
摘要 目的:研究探索蚁附蠲痹超细微粉对佐剂性关节炎大鼠TLR/TRAF/Fas信号转导的影响,为药物治疗类风湿性关节炎的临床作用机理研究提供药理学依据。方法:用完全弗氏佐剂(FCA)于大鼠右后足跖皮下注入踝关节,复制大鼠佐剂性关节炎模型。于造模当日开始给药,每天1次,连续给药21天,于末次给药后,无菌条件下取脾脏,进行相应操作,比较模型组与其他各组之间Faslg、TLR2和TRAF6基因mRNA表达量的变化情况。结果:与模型组比较,蚁附蠲痹超细微粉高、中、低剂量组Faslg、TLR2和TRAF6基因mRNA表达量明显降低。结论:蚁附蠲痹超细微粉具有良好的抗炎作用。 Objective:To investigate the effect of Yifu-Juanbi micropowder on the TLR/TRAF/Fas signal transduction of adjuvant arthritis rats and to provide the pharmacological basis for the treatment of arthritis deformans by drug.Method:The models of adjuvant arthritis rats was established by hypodermic injecting complete Freund's adjuvant(FCA)to its gambrels at the right metapedes voix pedis.And the drug was intragastric administrated to rat from the first day of model establishment for once a day,21 days in all.After the last administration,the spleen was taken out in asepsis condition.And the express of the mRNAs of Faslg,TLR2 and TRAF6 were compared between the model and other groups.Result:The express of the mRNAs of Faslg,TLR2 and TRAF6 of the groups of high,middle and low-dose of Yifu-Juanbi micropowder were decreased obviously compared with the model group.Conclusion:Yifu-Juanbi micropowder has superordinary anti-inflammatory effect.
出处 《中药与临床》 2010年第3期29-33,共5页 Pharmacy and Clinics of Chinese Materia Medica
基金 国家中医药管理局中医科技进步工程专项(06-07ZQ12)
关键词 蚁附蠲痹超细微粉 佐剂性关节炎 tlr/traf/fas信号转导 Yifu-Juanbi micropowder adjuvant arthritis TLR/TRAF/Fas signal transduction
  • 相关文献

参考文献7

二级参考文献65

  • 1李广清,汪悦.中医药治疗类风湿性关节炎的实验研究进展[J].甘肃中医,2004,17(7):44-46. 被引量:4
  • 2高淑红.针灸治疗类风湿性关节炎疗效观察[J].针灸临床杂志,2004,20(8):8-9. 被引量:13
  • 3杨燊,缪小平,张雪梅,孙瞳,曲世宁,熊萍,叶颖江,郭永丽,谭文,王杉,林东昕.凋亡相关基因FAS及其配体FASL基因单核苷酸多态与大肠癌风险[J].中华医学杂志,2005,85(30):2132-2135. 被引量:3
  • 4The International HapMap Consortium. The International HapMap Project. Nature, 2003,426:789--796.
  • 5Whiteside T L, Rabinovcich H. The role of Fas/FasL in immunosuppression induced by human tumors. Cancer Immunol Immunother, 1998,46:175 -184.
  • 6Leithauser F, Dhein J, Mechtersheimer G,et al. Constitutive and induced expression of APO 1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest, 1993,69 : 415-- 429.
  • 7Evan G I, Vousden K H. Proliferation, cell cycle and apoptosis in cancer. Nature, 2001,411:342--348.
  • 8Nagata S, Golstein P. The Fas death factor. Science, 1995, 267: 1449-- 1456.
  • 9Reichmann E. The biological role of the Fas/FasL system during tumor formation and progression. Semin Cancer Biol, 2002,12 : 309-- 315.
  • 10Kase H, Aoki Y, Tanaka K. Fas ligand expression in cervical adenocarcinoma: relevance to lymph node metastasis and tumor progression. Gynecol Oncol, 2003,90 :70-- 74.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部